Paper Review Records
All Paper Review Records
16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
38
days
piR-34379 inhibits bladder cancer progression and reverses cisplatin resistance by downregulating ACAT2-mediated PKM2 lactylation
Authors
Suyuelin Huang; Yuxiao Li; Yuchen Shi; Fenghao Zhang; Dingheng Lu; Kai Yu; Jiawei Zhang; Jihuan Yuan; Xiao Wang; Xueyou Ma; Jiangfeng Li; Jiazhu Sun; Ben LiuShow moreShow less
Affiliations
Department of Urology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China; Cancer Center, Zhejiang University, Hangzhou, Zhejiang, ChinaShow moreShow less
113
days
RNF34 restrains endometriosis progression by promoting PKM2 ubiquitination and suppressing glycolysis
Authors
Jiayu Liu; Jie Zhang; Qiaozhu Wu; Chao Lu; Zhenhai YuShow moreShow less
Affiliations
Department of Reproductive Medicine, Affiliated Hospital of Shandong Second Medical University, Weifang, Shandong Province, PR China; School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong Province, PR ChinaShow moreShow less
79
days
PREX1 regulates renal fibrosis through the RPTOR-mTORC1 signaling pathway
Authors
Xiangyang Geng; Guang Chen; Yong Qian; Weimin Shan; Xiaowei Li; Jiehao Zhou; Xiao WangShow moreShow less
Affiliations
Department of Urology, Fuyang People's Hospital of Anhui Medical University, Fuyang, Anhui 236012, China; Department of Nephrology, Fuyang People's Hospital of Anhui Medical University, Fuyang, Anhui 236012, China; Department of Emergency Surgery, Fuyang People's Hospital of Anhui Medical University, Fuyang, Anhui 236012, ChinaShow moreShow less
81
days
DRAM1 activates microglial pyroptosis and neuroinflammation through TMEM9-mediated lysosomal membrane permeabilization after spinal cord injury
Authors
Zhichao Xiong; Guangkui Yan; Jinfa Wu; Tiantain Xu; Jiangwei Chen; Jiaming Liu; Liuxue DuShow moreShow less
Affiliations
Department of Orthopedic Hospital, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China; Jiangxi Provincial Key Laboratory of Spine and Spinal Cord Disease, Nanchang 330006, China; Department of Pharmacy, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, ChinaShow moreShow less
105
days
Low-dose polysaccharides exert dual redox effects via the ROS-mediated MAPK pathway: Antioxidant alone or pro-oxidant when GLP is combined with doxorubicin in A2780 ovarian cancer cells
Authors
Yuqian Zhang; Xinru Li; Yutong Shen; Lijuan Yang; Min Yang; Xiaona Meng; Bandar Al-Hamyari; Yongyan Shi; Shengnan MengShow moreShow less
Affiliations
Department of Pharmaceutics, School of Pharmacy, China Medical University, Shenyang 110122, China; Department of Pediatrics, Shengjing Hospital of China Medical University, National Center for Children's Health, Shenyang 110004, ChinaShow moreShow less
92
days
miR-138-5p suppresses M2 macrophage polarization in esophageal squamous cell carcinoma via exosomes
Authors
Wei Xu; Yang Chen; Fei Teng; Shengwei Li; Zhiqiang WangShow moreShow less
Affiliations
Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China; Department of Thoracic Surgery, Chongqing University Cancer Hospital, Chongqing 400030, ChinaShow moreShow less
FAQ
How long does CELLULAR SIGNALLING take to review a manuscript?
As of 2026-11-19, CrushSCI has 16 complete review records for CELLULAR SIGNALLING. The fastest paper went from submission to acceptance in 38 days (piR-34379 inhibits bladder cancer progression and reverses cisplatin resistance by downregulating ACAT2-mediated PKM2 lactylation, received 2026-09-19, accepted 2026-10-27); the slowest took 201 days. The average is 104.8 days and the median is 104.5 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
